Loading...

Bio-Rad Laboratories, Inc.

BIO•NYSE
Healthcare
Medical - Devices
$287.84
$6.42(2.28%)
U.S. Market opens in 30h 28m

Bio-Rad Laboratories, Inc. (BIO) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.8B
P/E Ratio10.18
EPS (TTM)$27.85
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$260.72
3 Months$200.73
1 Year Target$150.39

BIO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $150.39.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.18 and a market capitalization of 7.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.25%
5-Day Change
-2.43%
1-Month Change
5.75%
3-Month Change
-2.97%
6-Month Change
-15.30%
Year-to-Date (YTD) Change
-5.03%
1-Year Change
15.22%
3-Year Change
-37.69%
5-Year Change
-55.62%
All-Time (Max) Change
11201.12%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

7,700 Employees
IPO DateFeb 27, 1980
CountryUS
Actively Trading

Frequently Asked Questions